Skip to content
6-K

Foreign Interim / Material

INTELLIPHARMACEUTICS INTERNATIONAL INC.

0001654954-23-012981

← back to feed
Filed
Oct 16, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2023 · Aug 31, 2023 $240.83K
Operating Cash Flow Q3 2023 · Aug 31, 2023 $316.38K
Operating Cash Flow Q3 2023 · Aug 31, 2022 −$293.15K
Operating Cash Flow Q3 2023 · Aug 31, 2022 −$1.19M
Stockholders Equity Q3 2023 · Aug 31, 2023 −$12.88M
Stockholders Equity Q3 2023 · May 31, 2023 −$12.88M
Stockholders Equity Q3 2023 · Nov 30, 2022 −$10.58M
Stockholders Equity Q3 2023 · May 31, 2022 −$9.86M
Stockholders Equity Q3 2023 · Nov 30, 2021 −$8.16M
Current Liabilities Q3 2023 · Aug 31, 2023 $14.44M
Current Liabilities Q3 2023 · Nov 30, 2022 $12.01M
Current Assets Q3 2023 · Aug 31, 2023 $861.9K
Current Assets Q3 2023 · Nov 30, 2022 $492.51K
Total Assets Q3 2023 · Aug 31, 2023 $1.57M
Total Assets Q3 2023 · Nov 30, 2022 $1.43M
Sga Expense Q3 2023 · Aug 31, 2023 $193.53K
Sga Expense Q3 2023 · Aug 31, 2023 $425.87K
Sga Expense Q3 2023 · Aug 31, 2022 $292.3K
Sga Expense Q3 2023 · Aug 31, 2022 $212.06K
Rd Expense Q3 2023 · Aug 31, 2023 $1.55M
Rd Expense Q3 2023 · Aug 31, 2023 $1.57M
Rd Expense Q3 2023 · Aug 31, 2022 $626.07K
Rd Expense restated Q3 2023 · Aug 31, 2022 $1.66M
Net Income Q3 2023 · Aug 31, 2023 −$1.89M
Net Income Q3 2023 · Aug 31, 2023 −$2.3M
Net Income Q3 2023 · May 31, 2023 −$2.3M
Net Income Q3 2023 · Aug 31, 2022 −$291.57K
Net Income restated Q3 2023 · Aug 31, 2022 −$2.01M
Net Income Q3 2023 · May 31, 2022 −$1.72M
Operating Income Q3 2023 · Aug 31, 2023 −$1.79M
Operating Income Q3 2023 · Aug 31, 2023 −$2.12M
Operating Income Q3 2023 · Aug 31, 2022 −$366.18K
Operating Income Q3 2023 · Aug 31, 2022 −$2.39M
Gross Profit Q3 2023 · Aug 31, 2023 −$805K
Gross Profit Q3 2023 · Aug 31, 2023 $1.55K
Gross Profit Q3 2023 · Aug 31, 2022 $19.07K
Gross Profit Q3 2023 · Aug 31, 2022 −$361.79K
Cost Of Revenue Q3 2023 · Aug 31, 2023 $17.43K
Cost Of Revenue Q3 2023 · Aug 31, 2023 $17.43K
Cost Of Revenue Q3 2023 · Aug 31, 2022 $0
Cost Of Revenue Q3 2023 · Aug 31, 2022 $397.83K